Fortis Healthcare Limited has informed the Exchange about final approval received from BSE limited approving the modifications/alterations of the terms of Debentures.
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fortis Healthcare has received final approval from BSE for changes to the terms of its existing debentures. This means the company has amended certain conditions on its already-issued debt instruments, with the stock exchange now clearing those changes. The specific nature of the modifications (such as coupon rate, maturity period, or other terms) is not detailed in the announcement. BSE's final approval indicates the regulatory process for these changes is now complete.
Modifications to existing debenture terms can affect investors by changing the income or repayment schedule they were originally promised. Shareholders should look for further details on which terms were altered and whether the changes are favourable or unfavourable for debenture holders.